| Karissa R Miller, MD | |
|
945 N 12th St, Milwaukee, WI 53233-1305 | |
| (715) 346-5000 | |
| Not Available |
| Full Name | Karissa R Miller |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 13 Years |
| Location | 945 N 12th St, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386933075 | NPI | - | NPPES |
| 100039147 | Medicaid | WI | |
| 61425-20 | Other | WI | WI STATE LIC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 61425 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora St Lukes Medical Center | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
Regenerx Biopharmaceuticals Inc. has announced the results of its Phase II clinical trial evaluating the safety and wound-healing efficacy of RGN-137 for the treatment of patients with venous stasis ulcers.
A new study by Ohio University faculty members showed that people who are afraid to have their blood drawn believe more people faint or have other symptoms than what statistics show actually occurs.
For-profit and non-profit organizations in Washington state will receive $1.25M in Proof of Concept grant funding to accelerate the translation of promising health-related technologies from concept to commercialization, the Life Sciences Discovery Fund (LSDF) announced today.
A new vision screening device, already shown to give an early warning of eye disease, could give doctors and patients a head start on treating diabetes and its vision complications, a new study shows.
› Verified 9 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
Regenerx Biopharmaceuticals Inc. has announced the results of its Phase II clinical trial evaluating the safety and wound-healing efficacy of RGN-137 for the treatment of patients with venous stasis ulcers.
A new study by Ohio University faculty members showed that people who are afraid to have their blood drawn believe more people faint or have other symptoms than what statistics show actually occurs.
For-profit and non-profit organizations in Washington state will receive $1.25M in Proof of Concept grant funding to accelerate the translation of promising health-related technologies from concept to commercialization, the Life Sciences Discovery Fund (LSDF) announced today.
A new vision screening device, already shown to give an early warning of eye disease, could give doctors and patients a head start on treating diabetes and its vision complications, a new study shows.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karissa R Miller, MD Po Box 735044, Chicago, IL 60673-5044 Ph: (414) 219-2000 | Karissa R Miller, MD 945 N 12th St, Milwaukee, WI 53233-1305 Ph: (715) 346-5000 |
News Archive
Regenerx Biopharmaceuticals Inc. has announced the results of its Phase II clinical trial evaluating the safety and wound-healing efficacy of RGN-137 for the treatment of patients with venous stasis ulcers.
A new study by Ohio University faculty members showed that people who are afraid to have their blood drawn believe more people faint or have other symptoms than what statistics show actually occurs.
For-profit and non-profit organizations in Washington state will receive $1.25M in Proof of Concept grant funding to accelerate the translation of promising health-related technologies from concept to commercialization, the Life Sciences Discovery Fund (LSDF) announced today.
A new vision screening device, already shown to give an early warning of eye disease, could give doctors and patients a head start on treating diabetes and its vision complications, a new study shows.
› Verified 9 days ago
Dr. Colleen Ann Crowe, M.D., M.P.H. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-6469 | |
Natalia Rumas, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2323 N Lake Dr, Milwaukee, WI 53211 Phone: 414-290-6720 Fax: 414-290-6755 | |
Adam C Ankrum, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 111 E Wisconsin Ave, Suite 2000, Milwaukee, WI 53202 Phone: 414-290-6720 Fax: 414-290-6755 | |
Andrea Michelle Kraus, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3237 S 16th St Ste 100, Milwaukee, WI 53215 Phone: 414-647-5203 Fax: 414-858-2236 | |
Lisa Hubbard, CFNP Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 5000 W Chambers St, Milwaukee, WI 53210 Phone: 414-447-2000 Fax: 414-874-4393 | |
Mr. Brad A. Johnson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 W Oklahoma Ave, Milwaukee, WI 53215 Phone: 414-649-6000 | |
Mckenna Jean Knych, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-6450 Fax: 414-805-6464 |